AIVL and Hepatitis Australia highlight international calls for NSPs in prisons, along with a greater focus on harm reduction initiatives.
No significant BBV/STI or AOD measures in Health Budget
AIVL has expressed disappointment there is little evidence of new investment in the AOD, BBV and STI sectors in the 2019 Health Budget.
Overdose Awareness Day: Calls for greater focus on harm reduction
AIVL is calling for a greater focus on key prevention and harm reduction initiatives on International Overdose Awareness Day.
AOD sector urges governments to seize opportunity to make long-lasting reforms
The AOD sector calls on governments to make permanent or expand on reforms introduced during the pandemic.
AIVL World Hepatitis Day Event 2020
Leading drug and infectious disease organisations unite to discuss COVID-19 impact on hepatitis C elimination in Australia on World Hepatitis Day.
The Juice – Information for Safer Gains
Hepatitis Australia/ AIVL joint project ‘The Juice’ is a dedicated resource for people who use performance and image enhancing drugs (PIEDs).
Harm Reduction International Conference postponed to 2023
The HR23 conference will be held in Melbourne in partnership with AIVL and other harm reduction service providers.
International Drug Users Day: UN calls for an end to criminalisation
AIVL is calling on governments to heed calls from the UN for an end to criminalisation on International Drug Users Day.
Government defies logic on welfare drug testing
The Social Services Legislation Amendment (Drug Testing Trial) Bill 2019 seeks to introduce drug testing for welfare recipients.
Mandatory testing of welfare recipients pointless given absence of treatment services
AIVL has expressed frustration at the revival of Australian Government plans to impose drug testing on welfare recipients.